Is 'Safe' snus actually safe? 30,000-Person study aims to find out
NCT ID NCT07573319
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study uses data from over 30,000 Swedish adults to see if using snus (including newer white nicotine pouches) is linked to heart disease, metabolic problems, and poor mental health, independent of smoking. Researchers will compare current, former, and never-users using advanced imaging and blood tests. The goal is to clarify the mixed evidence on snus safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
snus (including white nicotine pouches)
What this could lead to
If clear links are found, this could guide public health advice and regulation around snus use, especially for young people and women.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may be influenced by other lifestyle factors not fully accounted for.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENTAL HEALTH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Göteborg Universitetssjukhus
Gothenburg, Sweden
-
Karolinska Institutet Danderyds Sjukhus
Stockholm, Sweden
-
Skanes Universitetssjukhus, Lund Universitet
Lund, Sweden
-
Umeå Universitetssjukhus
Umeå, Sweden
-
Uppsala Universitetssjukhus
Uppsala, Sweden